340 related articles for article (PubMed ID: 188179)
41. Proliferative disorders of the plasma cell.
Boulter MJ
Am Fam Physician; 1982 Oct; 26(4):169-77. PubMed ID: 6812402
[TBL] [Abstract][Full Text] [Related]
42. A descriptive study of plasma cell dyscrasias in Egyptian population.
Kassem NM; El Zawam H; Kassem HA; El Nahas T; El Husseiny NM; El Azeeim HA
J Egypt Natl Canc Inst; 2014 Jun; 26(2):67-71. PubMed ID: 24841156
[TBL] [Abstract][Full Text] [Related]
43. [IgM multiple myeloma].
Calvo Villas J; Ramírez Sánchez M; Sicilia Guillén F
Sangre (Barc); 1997 Jun; 42(3):257-8. PubMed ID: 9381279
[No Abstract] [Full Text] [Related]
44. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
[TBL] [Abstract][Full Text] [Related]
45. [IgM myeloma. Apropos of a case].
Heron JF; Guaydier G; Loyau G; Laniece M; Mandart JC; Borel B; L'Hirondel JL; Dumas M; Foucault JP
Sem Hop; 1976 Dec; 52(44):2549-52. PubMed ID: 188198
[No Abstract] [Full Text] [Related]
46. Cytologic diagnosis of multiple myeloma and macroglobulinemia in effusions.
Gondos B; Miller TR; King EB
Ann Clin Lab Sci; 1978; 8(1):11-6. PubMed ID: 414650
[TBL] [Abstract][Full Text] [Related]
47. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
Ramont L; Ngoc PT; Pignon B; Maquart FX
Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
[TBL] [Abstract][Full Text] [Related]
48. Skeletal clues apparently distinguishing Waldenstrom's macroglobulinemia from multiple myeloma and leukemia.
Rothschild BM; Ruhli F; Rothschild C
Am J Hum Biol; 2002; 14(4):532-7. PubMed ID: 12112574
[TBL] [Abstract][Full Text] [Related]
49. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
[TBL] [Abstract][Full Text] [Related]
50. A review of Waldenstrom's macroglobulinemia.
McDermott MK; Bell EM
Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
[TBL] [Abstract][Full Text] [Related]
51. [Progression from Crow-Fukase syndrome with double gammopathy (IgM-kappa, IgG-lambda) to primary macroglobulinemia].
Fujii H; Yashige H; Kanoh T; Urata Y
Rinsho Ketsueki; 1991 Aug; 32(8):890-6. PubMed ID: 1942531
[TBL] [Abstract][Full Text] [Related]
52. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
53. Myeloma and macroglobulinemia: what are the criteria for diagnosis?
Stone MJ
Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951
[TBL] [Abstract][Full Text] [Related]
54. Polymeric (presumed tetrameric) lambda Bence Jones proteinemia without proteinuria in a patient with multiple myeloma.
Hom BL
Am J Clin Pathol; 1984 Nov; 82(5):627-9. PubMed ID: 6437210
[TBL] [Abstract][Full Text] [Related]
55. IgM myeloma--its distinction from Waldenström's macroglobulinemia.
Takahashi K; Yamamura F; Motoyama H
Acta Pathol Jpn; 1986 Oct; 36(10):1553-63. PubMed ID: 3099541
[TBL] [Abstract][Full Text] [Related]
56. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
[TBL] [Abstract][Full Text] [Related]
57. [Dysproteinemic plasmacytomiatic diseases from the gerontologic viewpoint].
Di Guglielmo R; Guidi G
G Gerontol; 1968 Oct; 16(10):1119-31. PubMed ID: 4980444
[No Abstract] [Full Text] [Related]
58. [Cutaneous Waldenström's macroglobulinemia].
Mantoux F; Castanet J; Perrin C; Fuzibet JG; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):53-5. PubMed ID: 11937931
[TBL] [Abstract][Full Text] [Related]
59. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
[TBL] [Abstract][Full Text] [Related]
60. [Fanconi syndrome in an adult coincident with early myeloma with monoclonal IgG, type kappa, anomaly (author's transl)].
Walb D; Wohlenberg H; Rumpelt HJ; Schmidt H; Thomas L
Dtsch Med Wochenschr; 1980 Sep; 105(39):1355-9. PubMed ID: 6257469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
